Former NFL running back Chris Johnson, who retired from professional football a decade ago, announced this week that he has been diagnosed with amyotrophic lateral sclerosis, commonly known as ALS. The revelation came during an appearance on Good Morning America, where the 40‑year‑old detailed the shock of learning he has a disease that typically spares families with no known history.
A Diagnosis Without Precedent
Medical professionals told Johnson that his case appears to be sporadic, meaning the cause is not linked to inherited genetic factors. The news forced the former Tennessee Titans star to confront a reality he had not anticipated, and he admitted that full acceptance of the diagnosis still feels out of reach.
Johnson emphasized that he intends to fight the illness on every front, drawing on the same competitive spirit that defined his career on the field. He described his approach as a blend of physical training, mental resilience, and a relentless pursuit of any avenue that might slow progression.
Support From Former Teams and the League
Owner Amy Adams Strunk of the Tennessee Titans issued a public statement expressing deep admiration for Johnson’s contributions to the franchise and offering unwavering support as he navigates his health battle. The New York Jets and Arizona Cardinals, also former employers of the running back, echoed the sentiment, highlighting his lasting impact on each organization.
The National Football League released a brief comment affirming its commitment to player health initiatives and pledging to assist Johnson in any way possible. The league’s statement underscored the broader community’s willingness to rally around one of its own, reinforcing the notion that the sport’s reach extends beyond the field.
While the diagnosis presents formidable challenges, Johnson’s public disclosure has sparked a conversation about ALS awareness, early detection, and the importance of research funding. His willingness to share his journey invites fans, teammates, and medical professionals alike to consider new ways of supporting those affected by the disease.